Skip to main content
Erschienen in: BMC Cancer 1/2023

Open Access 01.12.2023 | Research

Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer

verfasst von: Pengfei Tong, Danqi Sun, Guangqiang Chen, Jianming Ni, Yonggang Li

Erschienen in: BMC Cancer | Ausgabe 1/2023

Abstract

Background

Preoperative assessment of lymphovascular invasion(LVI) of rectal cancer has very important clinical significance. However, accurate preoperative imaging evaluation of LVI is highly challenging because the resolution of MRI is still limited. Relatively few studies have focused on prediction of LVI of rectal cancer with the tool of radiomics, especially in patients with negative statue of MRI-based extramural vascular invasion (mrEMVI).The purpose of this study was to explore the preoperative predictive value of biparametric MRI-based radiomics features for LVI of rectal cancer in patients with the negative statue of mrEMVI.

Methods

The data of 146 cases of rectal adenocarcinoma confirmed by postoperative pathology were retrospectively collected. In the cases, 38 had positive status of LVI. All patients were examined by MRI before the operation. The biparametric MRI protocols included T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI). We used whole-volume three-dimensional method and two feature selection methods, minimum redundancy maximum relevance (mRMR) and least absolute shrinkage and selection operator (LASSO), to extract and select the features. Logistics regression was used to construct models. The area under the receiver operating characteristic curve (AUC) and DeLong’s test were used to evaluate the diagnostic performance of the radiomics based on T2WI and DWI and the combined models.

Results

Radiomics models based on T2WI and DWI had good predictive performance for LVI of rectal cancer in both the training cohort and the validation cohort. The AUCs of the T2WI model were 0.87 and 0.87, and the AUCs of the DWI model were 0.94 and 0.92. The combined model was better than the T2WI model, with AUCs of 0.97 and 0.95. The predictive performance of the DWI model was comparable to that of the combined model.

Conclusions

The radiomics model based on biparametric MRI, especially DWI, had good predictive value for LVI of rectal cancer. This model has the potential to facilitate the clinical recognition of LVI in rectal cancer preoperatively.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12885-023-10534-w.
Pengfei Tong and Danqi Sun contributed equally to this study.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AUC
Area under the receiver operating characteristics curve
CI
Confidence interval
DWI
Diffusion-weighted imaging
FOV
Field of view
GLCM
Gray-level co-occurrence matrix
GLRLM
Gray-level run-length matrix
GLSZM
Gray-level size zone matrix
GLDM
Gray-level dependence matrix
ICCs
Intraclass correlation coefficients
LASSO
Least absolute shrinkage and selection operator
LVI
Lymphovascular invasion
MRI
Magnetic resonance imaging
mRMR
Minimum redundancy maximum relevance
Radscore
Radiomics score
ROC
Receiver operating characteristic
SD
Standard deviation T2WI:T2-weighted imaging
TR
Repetition time
TE
Echo time
mrEMVI
MRI-based extramural vascular invasion

Background

Colorectal cancer is a common malignant tumor of the digestive tract. The global morbidity and mortality rates associated with colorectal cancer have been increasing in recent years. This cancer is the second most common cause of cancer-related death, and rectal cancer accounts for one-third of the incidence of colorectal cancer [1, 2]. At present, surgical resection combined with neoadjuvant chemoradiotherapy is the main treatment for rectal cancer [24]. Previous studies have shown that invasion of tumor cells into the microcirculation around the rectum increases the risk of spread and metastasis of rectal cancer. Vascular invasion of rectal cancer is an independent risk factor for postoperative tumor recurrence and low tumor-free survival [5, 6]. A recent study showed that lymphovascular invasion(LVI), rather than the traditionally believed depth of tumor invasion, is even a key risk factor for early rectal cancer metastasis [7]. Therefore, preoperative assessment of LVI of rectal cancer, including identification of small lymphatic and vascular invasion, has very important clinical significance for predicting postoperative recurrence, metastasis, and tumor-free survival of rectal cancer.
High-resolution magnetic resonance imaging (MRI) is the main imaging method for rectal cancer, and it plays a very important role in assessment of the tumor in the preoperative and postoperative periods. Biparametric MRI, including T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI), has demonstrated reliable results in the detection and staging of rectal cancer [8]. High-resolution MRI shows good performance in the demonstration of larger vessels. In the detection of extramural vascular invasion(EMVI),MRI has moderate sensitivity and high specificity. However, MRI cannot definitively depict vessels with a diameter of < 3 mm, including micro-arteriovenous and lymphatic vessels [9, 10]. Therefore, accurate preoperative imaging evaluation of LVI of rectal cancer is highly challenging.
Radiomics relies on algorithm models to extract quantitative imaging features that cannot be captured by visual inspection. The selected radiomics features can be used to establish predictive model related to disease diagnosis and treatment combined with clinical and pathological data. At present, radiomics as an emergent imaging analysis is widely used in the imaging studies of tumor diagnosis, post-treatment, and prognosis evaluation [1113]. In the study of rectal cancer, research has shown that radiomics has good predictive value for nodal metastasis and extramural venous invasion as well as evaluation of neoadjuvant radiotherapy and chemotherapy in patients with rectal cancer [14]. However, relatively few studies have focused on preoperative prediction of LVI of rectal cancer especially in patients with the negative statue of MRI-based extramural vascular invasion(mrEMVI).
The present study was performed to explore the preoperative predictive value and role of biparametric MRI-based radiomic features for LVI of rectal cancer in patients with the negative statue of mrEMVI.

Materials and methods

Patients

Cases of rectal adenocarcinoma confirmed by surgery and postoperative pathology were retrospectively collected from 2019 to 2021. The inclusion criteria were rectal adenocarcinoma confirmed by surgery and postoperative pathology, examination by noncontrast-enhanced MRI before the operation, and confirmation of the status of LVI by postoperative pathology. The exclusion criteria were patients with treatment before the operation; patients with the positive statue of mrEMVI; incomplete imaging or clinical and pathological data; poor image quality of MRI before the operation, affecting the imaging diagnosis; and a > 1-month interval between the MRI examination and operation. Finally, 146 cases were included. A study flow chart is shown in Fig. 1.

Image acquisition

All patients underwent preoperative MRI examinations with a Siemens Skyra 3.0 T system (Siemens Healthineers, Erlangen, Germany), and intestinal cleaning and preparation were performed before the examination. The biparametric MRI protocols included T2WI and DWI. Images from each sequence were obtained in the oblique coronal, oblique axial, and sagittal planes. The oblique axial plane was determined by the perpendicular axis of the tumor, and the oblique coronal plane was parallel to the tumor axis or anal canal depending on the location of the tumor. The details of the scanning sequences are shown in Table 1.
Table 1
Rectal MRI scanning parameters
 
T2WI
DWI
Parameter
 
b = 0,1000 s/mm2
Anatomical planes
oblique axial
oblique coronal
sagittal
oblique axial
oblique coronal
sagittal
FOV(mm)
200
250
Slice thickness(mm)
3.0
3.0
TR(ms)
4200
5780
TE(ms)
101
78
Matrix
320 × 320
320 × 320
T2WI T2-weighted imaging, DWI Diffusion-weighted imaging, FOV Field of view, TR Repetition time, TE Echo time

Reference standard for lymphovascular invasion

The reference standard for LVI of rectal cancer was the presence of tumor cells in lymphatic vessels and/or blood vessels in the resected specimen by postoperative pathology. The surface of tumor cells is covered with endothelial cells or thrombosis is found in blood vessels.

Image interpretation and segmentation

The patients were randomly divided into a training group (n = 102) and a validation group (n = 44) at a proportion of 7:3. Previous research has established that the signal intensity of rectal adenocarcinoma on T2WI is higher than that of the muscularis propria but lower than that of the submucosa. On high b-value DWI, the foci of the lesions show significantly higher signal intensity than the normal rectal wall, and the corresponding apparent diffusion coefficient map shows significantly lower signal intensity [15]. In the present study, a physician who had specialized in abdominal imaging for 8 years (reader1) used ITK-SNAP software (version 3.8.0, http://​www.​itksnap.​org/​pmwiki/​pmwiki.​php?​n=​Main.​Publications) to evaluate T2WI and DWI of all planes and delineate the regions of interest on oblique axial images independently. The region of the tumor was identified with reference to the relevant imaging diagnostic criteria [1618]. The whole-volume three-dimensional delineation method was used in this process as shown in Fig. 2. After one week, 30 cases were randomly selected and delineated by reader 1 and another physician with 12 years of diagnostic experience (reader 2), respectively, after training. The delineation interval between T2WI and DWI of the same patient was more than one day.

Radiomics feature extraction and model construction

The radiomics features were extracted using PyRadiomics software version 3.0.1 (https://​pyradiomics.​readthedocs.​io/​en/​latest/​index.​html) [19], which met the criteria of the Image Biomarker Standardization Initiative (https://​theibsi.​github.​io). The first-order features, shape-based features, and texture features based on Gray-level co-occurrence matrix(GLCM), Gray-level run-length matrix (GLRLM), Gray-level size zone matrix(GLSZM) and Gray-level dependence matrix(GLDM) were extracted, except for the original image.The texture features are also described as the second-order features that describe the intensity level of the spatial distribution of voxels.We also transformed the image using the Laplacian of Gaussian (sigma: 2, 3, 4, 5) and wavelet transformations. In total, 1218 radiomics features were obtained for each image. The default MRI extraction settings provided by PyRadiomics were adopted to extract the features. The basic settings were as follows: resample pixel spacing: 1 × 1 × 1, bin width: 5, normalize: true, and normalize scale: 100. Further details are provided in the Supplemental materials 1 and 2.
The radiomics features of 30 cases delineated by 2 physicians were calculated, and the intra-observer and inter-observer reproducibility of the radiomics features were evaluated. The radiomics features with poor reproducibility should he ruled out.We then used two feature selection methods, minimum redundancy maximum relevance (mRMR) and least absolute shrinkage and selection operator (LASSO), to select the features. First, mRMR was performed to eliminate the redundant and irrelevant features, and 30 features were retained. LASSO was then conducted to choose the optimized subset of features to construct the final model. LASSO involved choosing the regular parameter λ and determining the number of features. After the number of features had been determined, the most predictive subset of features was chosen and the corresponding coefficients were evaluated.
The radiomics score (Radscore) was calculated by summing the selected features weighted by their coefficients using the following formula: \(\mathrm y^\wedge=\mathrm b1\mathrm X1+\mathrm b2\mathrm X2+\cdots+\mathrm{biXi}+\mathrm b\), where y^ is the Radscore, b is the intercept, bi is the coefficient of the feature i, and Xi is the value of the feature i. In this way, the Radscore was calculated by summing the selected features weighted by their coefficients.

Statistical analysis

All statistical analyses were performed with R software version 4.0.3 (https://​cran.​r-project.​org). Continuous variables are expressed as mean and standard deviation, and categorical variables are expressed as frequency and percentage. The t test or rank sum test was used to analyze differences between groups of continuous variables, the chi-square test or Fisher’s test was used for unordered categorical variables, and the rank sum test was used for ordered categorical variables. The intraclass correlation coefficients (ICCs) was used to assess the intra-observer and inter-observer reproducibility of extraction. The ICCs < 0.7 was considered to have poor reproducibility. LASSO regression was used to select radiomics feature parameters, and logistics regression was used to construct model equations. The receiver operating characteristic (ROC) Curves and the area under the receiver operating characteristics curve (AUC) and DeLong’s test were used to evaluate the predictive performance among different models. A P-value of < 0.05 was considered statistically significant.

Results

In total, 146 cases of rectal cancer were included in this study (102 cases in the training group, 44 cases in the validation group). Of these 146 cases, 38 were positive for lymphovascular invasion. There were no significant differences in the clinical or pathological results between the groups. The details are shown in Table 2.
Table 2
Clinical and pathological characteristics of patients in training and validation groups
Characteristics
Training group n = 102
Validation group n = 44
P value
Gender,No.(%)
  
0.217
 Male
71 (69.6)
26 (59.1)
 
 Female
31 (30.4)
18 (40.9)
 
Age(mean years,SD)
62.96 (11.78)
62.32 (12.67)
0.768
Location, No.(%)
  
0.954
 high
35 (34.3)
14 (31.8)
 
 middle
44 (43.1)
20 (45.5)
 
 low
23 (22.6)
10 (22.7)
 
Grade, No.(%)
  
0.876
 Well
14 (13.7)
6 (13.6)
 
 Moderate
75 (73.5)
31 (70.5)
 
 Poor
13 (12.8)
7 (15.9)
 
pT stage, No.(%)
  
0.747
 T1-2
32 (31.4)
15 (34.1)
 
 T3a-b
70 (68.6)
29 (65.9)
 
pN stage, No.(%)
  
0.886
 N0
52 (51.0)
23 (52.3)
 
 N1a-b
50 (49.0)
21 (47.7)
 
Lymphovascular invasion, No.(%)
  
0.853
 positive
27 (26.5)
11 (25.0)
 
 negtive
75 (73.5)
33 (75.0)
 
Unless otherwise stated, data are presented as number of patients and percentages are shown in parentheses. SD Standard deviation, pT stage Pathology-based T stage, pN stage pathology-based N stage
The ICCs of the intra-observer and inter-observer reproducibility were satisfactory. Finally,11 and 14 radiomics features were retained from the T2WI and DWI sequences, respectively. 14 characteristic parameters were retained from the combined model. The details are shown in Fig. 3. The Radscore equations were included in Supplemental materials 1 and 2.
The receiver operating characteristics curve showed that the radiomics model based on T2WI and DWI had good predictive performance for lymphovascular invasion of rectal cancer in both the training cohort and the validation cohort. The AUCs of the T2WI model were 0.87 and 0.87 and the AUCs of the DWI model were 0.94 and 0.92. DeLong’s test showed that the DWI model had better performance than the T2WI model (P < 0.05) and that the combined model had better performance than the T2WI model, with AUCs of 0.97 and 0.95 in the training cohort and validation cohort, respectively (P < 0.05). The DWI model had predictive performance comparable to that of the combined model (P > 0.05) (Table 3, Fig. 4). There was an example as shown in Fig. 5. The calibration curves of the combined model demonstrated the best agreement with the ideal curve ( Fig. 6). The decision curves analysis showed that the combined model had the highest standardized net benefit across the range of 0.1–1.0 of the high risk threshold( Fig. 7).
Table 3
Predictive performance of different models in training and validation groups
  
Training group
  
Validation group
  
Models
AUC (95%CI)
Accuracy
Sensitivity
Specificity
AUC (95%CI)
Accuracy
Sensitivity
Specificity
cutoff
T2WI model
0.873 (0.804–0.941)
0.760
0.889
0.714
0.869 (0.728–1.00)
0.721
0.909
0.656
-1.12
DWI model
0.943 (0.883–1.000)
0.917
0.895
0.922
0.922 (0.836–1.000)
0.850
0.875
0.844
-0.749
Combined model
0.973 (0.945–1.000)
0.906
0.947
0.896
0.949 (0.880–1.000)
0.875
1.000
0.781
-1.26
AUC Area under the receiver operating characteristics curve, CI Confidence interval, T2WI T2-weighted imaging, DWI Diffusion-weighted imaging

Discussion

High-resolution MRI is currently the main imaging modality for preoperative and postoperative evaluation of patients with rectal cancer, but it cannot be used to obtain a clear diagnosis of small lymphovascular invasion. The present study was performed to explore the preoperative predictive value of biparametric MRI based radiomics features for LVI of rectal cancer, and the results showed that the radiomics models based on T2WI and DWI had good performance. A recent study of rectal cancer showed that a multiparameter radiomics model had good performance in predicting extramural venous invasion of rectal cancer [20]. In the present study, pathologically confirmed cases of LVI were included. Therefore, the evaluation of microcirculation invasion of rectal cancer was more comprehensively in our study. We selected biparametric images, including those obtained from T2WI and DWI sequences, to delineate lesions in this study for several reasons. On the one hand, the biparametric images are easier to obtain clinically than enhanced images with lower economic cost and a shorter inspection time, which is helpful for multicenter research. Without intravenous injection of gadolinium contrast agent, there is no potential risk of residual contrast agent in the body [21, 22]. On the other hand, previous studies have shown that enhanced T1WI has a limited role in staging of rectal cancer and cannot effectively distinguish the signal intensity of the lesions from that of the rectal wall [23, 24]. T2WI and DWI are the most important sequences for the imaging staging of rectal cancer and are effective in demonstrating the lesions [18, 25]. In addition, the whole-tumor three-dimensional method of delineation was used in this study for two reasons. First, because of the limited resolution of MRI, we could not identify the small-diameter arteriovenous and lymphatic vessels on the images directly. It was difficult to accurately delineate. Second, the three-dimensional method can more accurately and fully characterize the voxel characteristics than the two-dimensional method, as shown in previous studies [26, 27]. In recent years, there have been several studies similarly exploring the role of MRI based radiomics for LVI in patients with rectal cancer [28, 29].But differently, we focused on those patients with negative statue of mrEMVI. As the previous evidence showed, MRI has high specificity but moderate sensitivity in the detection of EMVI. There is no need for patients with positive statue of mrEMVI on the basis of routine MRI evaluation to offer extra imaging method for prediction of lymphovasular invasion.
In this study, the results showed that the AUCs of the radiomics models based on T2WI and DWI in the training cohort were 0.87 and 0.87, and those in the validation cohort were 0.94 and 0.92. The AUCs of the combined model were 0.97 and 0.95 in the training cohort and validation cohort, respectively.The results were better than previous study mentioned above.The probable reasons were as follows. First, the patients in our cohort were all evaluated as mrEMVI(-) preoperately. Consequently, the ratio of early stage patients was higher in our study compared with the previous studies. The cystic and necrotic components in early stage rectal cancer are less than advanced stage.Second, we delineated on biparametric MR images rather than multiparametric or multimodal images,which made the process easier and avoid the possibility of making mistakes in delineation on enhamced images.Third, we ruled out the cases of rectal mucinous adenocarcinoma. Rectal mucinous adenocarcinoma is a rare subtype of rectal adenocarcinoma characterized by lakes of stromal mucin containing scant malignant epithelial cells [30, 31]. Thus, it is difficult to identify the solid component on images. The extent of the tumor can be overestimated. As a result, the delineation of the lesions in our study was easier and more accurate.
Moreover, the discrimination of each model was compared. The results showed that the combined model was better than the T2WI model. Interestingly, the AUC of the DWI model was higher than that of the T2WI model and comparable to that of the combined model. As we know, DWI can detect the motion of water molecules in the extracellular and intracellular spaces in vivo, which reflects the cell membrane integrity and cell density [32]. Previous studies have shown that high b-value DWI can improve the accuracy of imaging staging of rectal cancer and has a role in distinguishing tumor foci and fibrous reactions after neoadjuvant chemoradiotherapy [3335]. In rectal adenocarcinoma, although the component of necrosis and cysts can increase the diffusion, the solid component consisting of the tumor cells always causes diffusion to become restricted. Consequently, the region of tumor cells demonstrates much higher signal intensity than the rectal wall on DWI, which is helpful in detecting the tumor regions and facilitating more accurate delineation. Additionally, the regions of interest on DWI may better characterize tumors and include more biological information than T2WI because DWI has the capability to reflect the tumor microenvironment. Furthermore, the calibration and clinical applicability of the models were taken into consideration. The results showed the combined model demonstrated the best degree of calibration and clinical applicability. The results showed that the combined model can effectively predict LVI of rectal cancer in patients with the mrEMVI (-). DWI was helpful in discriminating the status of LVI in this study.
This study had some limitations. First, the sample size was not large enough. Large-sample multicenter studies are still needed. Second, patients who underwent preoperative neoadjuvant radiotherapy and chemotherapy were excluded. There will be selection bias in this cohort of patients.Third, because of the limited sample size, cases of vascular and lymphatic invasion were not separately divided into groups. Fourth, this was a retrospective study. Finally, the patients’ clinicopathological data was not included in the predictive model.
In conclusion, the radiomics model based on bipapametric MRI showed good preoperative predictive value for lymphovascular invasion of rectal cancer with the mrEMVI (-). Radiomics from bipapametric MRI has the potential to serve as a noninvasive and effective biomarker to predict the status of lymphovascular invasion in rectal cancer preoperatively.

Acknowledgements

Not applicable.

Declarations

All experimental protocols were approved by Ethics Committee of the Affiliated Wuxi NO.2 People's Hospital of Nanjing Medical University,First Affiliated Hospital of Soochow University and the Second Affiliated Hospital of Soochow University.All methods were carried out in accordance with relevant guidelines and regulations.Informed consent was obtained from all participants or, if participants are under 18, from a parent and/or legal guardian.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRef
2.
Zurück zum Zitat Franke AJ. Skelton WPt, George TJ, Iqbal A: A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021;20(1):1–19.CrossRef Franke AJ. Skelton WPt, George TJ, Iqbal A: A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021;20(1):1–19.CrossRef
3.
Zurück zum Zitat Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther. 2021;21(2):193–203.CrossRef Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther. 2021;21(2):193–203.CrossRef
4.
Zurück zum Zitat Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020;100(3):615–28.CrossRef Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020;100(3):615–28.CrossRef
5.
Zurück zum Zitat Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, Wu AW, Sun YS. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677–85.CrossRef Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, Wu AW, Sun YS. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677–85.CrossRef
6.
Zurück zum Zitat Lee ES, Kim MJ, Park SC, Hur BY, Hyun JH, Chang HJ, Baek JY, Kim SY, Kim DY, Oh JH. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance. Eur Radiol. 2018;28(2):496–505.CrossRef Lee ES, Kim MJ, Park SC, Hur BY, Hyun JH, Chang HJ, Baek JY, Kim SY, Kim DY, Oh JH. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance. Eur Radiol. 2018;28(2):496–505.CrossRef
7.
Zurück zum Zitat Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg. 2022;275(1):e148–54.CrossRef Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg. 2022;275(1):e148–54.CrossRef
8.
Zurück zum Zitat Horvat N, Petkovska I, Gollub MJ. MR Imaging of Rectal Cancer. Radiol Clin North Am. 2018;56(5):751–74.CrossRef Horvat N, Petkovska I, Gollub MJ. MR Imaging of Rectal Cancer. Radiol Clin North Am. 2018;56(5):751–74.CrossRef
9.
Zurück zum Zitat Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, John R, Singh A, Ram TS, Jesudason MR, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2022;24(4):428-438. Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, John R, Singh A, Ram TS, Jesudason MR, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2022;24(4):428-438.
10.
Zurück zum Zitat Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.CrossRef Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.CrossRef
11.
Zurück zum Zitat Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132-146. Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132-146.
12.
Zurück zum Zitat Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Jain R, Lee SK. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol. 2020;30(7):3834–42.CrossRef Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Jain R, Lee SK. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol. 2020;30(7):3834–42.CrossRef
13.
Zurück zum Zitat Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57. Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57.
14.
Zurück zum Zitat Hou M, Sun JH. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives. World J Gastroenterol. 2021;27(25):3802–14.CrossRef Hou M, Sun JH. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives. World J Gastroenterol. 2021;27(25):3802–14.CrossRef
15.
Zurück zum Zitat Akasu T, Iinuma G, Fujita T, Muramatsu Y, Tateishi U, Miyakawa K, Murakami T, Moriyama N. Thin-section MRI with a phased-array coil for preoperative evaluation of pelvic anatomy and tumor extent in patients with rectal cancer. AJR Am J Roentgenol. 2005;184(2):531–8.CrossRef Akasu T, Iinuma G, Fujita T, Muramatsu Y, Tateishi U, Miyakawa K, Murakami T, Moriyama N. Thin-section MRI with a phased-array coil for preoperative evaluation of pelvic anatomy and tumor extent in patients with rectal cancer. AJR Am J Roentgenol. 2005;184(2):531–8.CrossRef
16.
Zurück zum Zitat Horvat N. Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ: MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367–87.CrossRef Horvat N. Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ: MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367–87.CrossRef
17.
Zurück zum Zitat Moreno CC, Sullivan PS, Mittal PK. Rectal MRI for Cancer Staging and Surveillance. Gastroenterol Clin North Am. 2018;47(3):537–52.CrossRef Moreno CC, Sullivan PS, Mittal PK. Rectal MRI for Cancer Staging and Surveillance. Gastroenterol Clin North Am. 2018;47(3):537–52.CrossRef
18.
Zurück zum Zitat Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.CrossRef Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.CrossRef
19.
Zurück zum Zitat van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational Radiomics System to Decode the Radiographic Phenotype. Can Res. 2017;77(21):e104–7.CrossRef van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational Radiomics System to Decode the Radiographic Phenotype. Can Res. 2017;77(21):e104–7.CrossRef
20.
Zurück zum Zitat Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32(2):1002-1013. Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32(2):1002-1013.
21.
Zurück zum Zitat McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772–82.CrossRef McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772–82.CrossRef
22.
Zurück zum Zitat Kanda T, Matsuda M, Oba H, Toyoda K, Furui S. Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;277(3):924–5.CrossRef Kanda T, Matsuda M, Oba H, Toyoda K, Furui S. Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;277(3):924–5.CrossRef
23.
Zurück zum Zitat Gürses B, Böge M, Altınmakas E, Balık E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019;25(3):175–82.CrossRef Gürses B, Böge M, Altınmakas E, Balık E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019;25(3):175–82.CrossRef
24.
Zurück zum Zitat Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG. Rectal cancer: MR imaging in local staging–is gadolinium-based contrast material helpful? Radiology. 2005;234(1):179–88.CrossRef Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG. Rectal cancer: MR imaging in local staging–is gadolinium-based contrast material helpful? Radiology. 2005;234(1):179–88.CrossRef
25.
Zurück zum Zitat Curvo-Semedo L. Rectal Cancer: Staging. Magn Reson Imaging Clin N Am. 2020;28(1):105–15.CrossRef Curvo-Semedo L. Rectal Cancer: Staging. Magn Reson Imaging Clin N Am. 2020;28(1):105–15.CrossRef
26.
Zurück zum Zitat Huang J, Chen Y, Zhang Y, Xie J, Liang Y, Yuan W, Zhou T, Gao R, Wen R, Xia Y, et al. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer. Abdom Radiol (NY). 2022;47(1):66–75.CrossRef Huang J, Chen Y, Zhang Y, Xie J, Liang Y, Yuan W, Zhou T, Gao R, Wen R, Xia Y, et al. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer. Abdom Radiol (NY). 2022;47(1):66–75.CrossRef
27.
Zurück zum Zitat Wan Q, Zhou J, Xia X, Hu J, Wang P, Peng Y, Zhang T, Sun J, Song Y, Yang G, et al. Diagnostic Performance of 2D and 3D T2WI-Based Radiomics Features With Machine Learning Algorithms to Distinguish Solid Solitary Pulmonary Lesion. Front Oncol. 2021;11:683587.CrossRef Wan Q, Zhou J, Xia X, Hu J, Wang P, Peng Y, Zhang T, Sun J, Song Y, Yang G, et al. Diagnostic Performance of 2D and 3D T2WI-Based Radiomics Features With Machine Learning Algorithms to Distinguish Solid Solitary Pulmonary Lesion. Front Oncol. 2021;11:683587.CrossRef
28.
Zurück zum Zitat Zhang Y, He K, Guo Y, Liu X, Yang Q, Zhang C, Xie Y, Mu S, Guo Y, Fu Y, et al. A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer. Front Oncol. 2020;10:457.CrossRef Zhang Y, He K, Guo Y, Liu X, Yang Q, Zhang C, Xie Y, Mu S, Guo Y, Fu Y, et al. A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer. Front Oncol. 2020;10:457.CrossRef
29.
Zurück zum Zitat Zhang K, Ren Y, Xu S, Lu W, Xie S, Qu J, Wang X, Shen B, Pang P, Cai X, et al. A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer. Med Phys. 2021;48(9):4872–82.CrossRef Zhang K, Ren Y, Xu S, Lu W, Xie S, Qu J, Wang X, Shen B, Pang P, Cai X, et al. A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer. Med Phys. 2021;48(9):4872–82.CrossRef
30.
Zurück zum Zitat Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, Gu J. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13(12):1567–83.CrossRef Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, Gu J. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13(12):1567–83.CrossRef
31.
Zurück zum Zitat Horvat N, Hope TA, Pickhardt PJ, Petkovska I. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019;44(11):3569–80.CrossRef Horvat N, Hope TA, Pickhardt PJ, Petkovska I. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019;44(11):3569–80.CrossRef
32.
Zurück zum Zitat Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRef Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRef
33.
Zurück zum Zitat Kalisz KR, Enzerra MD, Paspulati RM. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy. Radiographics. 2019;39(2):538–56.CrossRef Kalisz KR, Enzerra MD, Paspulati RM. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy. Radiographics. 2019;39(2):538–56.CrossRef
34.
Zurück zum Zitat Lambregts D, Rao S, Sassen S, Martens M, Heijnen L, Buijsen J, Sosef M, Beets G, Vliegen R, Beets-Tan R. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study. Ann Surg. 2015;262(6):1034–9.CrossRef Lambregts D, Rao S, Sassen S, Martens M, Heijnen L, Buijsen J, Sosef M, Beets G, Vliegen R, Beets-Tan R. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study. Ann Surg. 2015;262(6):1034–9.CrossRef
35.
Zurück zum Zitat Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863–70.CrossRef Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863–70.CrossRef
Metadaten
Titel
Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer
verfasst von
Pengfei Tong
Danqi Sun
Guangqiang Chen
Jianming Ni
Yonggang Li
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2023
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10534-w

Weitere Artikel der Ausgabe 1/2023

BMC Cancer 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.